Incyte Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi® (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years […]
WILMINGTON, Del.—The U.S. Food and Drug Administration has approved AstraZeneca’s QTERN for the treatment of type 2 diabetes. The new medicine aims to improve blood-sugar-level control in adults with type […]
A series of upcoming workshops, offered by the University of Delaware, aim to help fruit and vegetable growers comply with new federal laws. In 2013, the U.S. Food and Drug […]
© 2024 Delaware Business Times